Below you will find a replay of the Global Innovators webcast with Portfolio Managers, Dr. Ian Mortimer and Mr. Matthew Page.     

https://vimeo.com/189066660/cc09dc2de4

Click here for a PDF version of the webcast presentation slides.

Summarized highlights:

  • In the third quarter of 2016, the Guinness Atkinson Global Innovators Fund, ticker GINNX, began to see a rebound in its value oriented innovative portfolio as it outperformed its benchmark rising 9.76% in the institutional share class vs. the MSCI World Index, which was up 4.99%. 
  • In the quarter we made four changes to the portfolio; we sold positions in Oracle and Tegna and initiated new positions in Infineon and Shire.  
  • During the quarter, the top 5 performers were NVIDIA, State Street, Qualcomm, Applied Material, SAP
  • The bottom 5 performers were Cognizant, Verifone, Tegna, Gilead Sciences and Oracle

Performance                   as of 9/30/16

 YTD 1-Year 3-Years 5-Years  10-Years Since Inception

Global Innovators Fund, Investor Class

 7.18% 15.29% 9.50% 17.21% 8.67% 6.90%
Global Innovators Fund, Institutional Class 7.40% 15.53% 9.57% 17.26% 8.69% 6.92%
MSCI World Index 6.06%  12.04%  6.48% 12.29% 5.11% 5.09%

 

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Fund may be lower or higher than the performance quoted. For performance current to most recent month end please visit www.gafunds.com. Total returns reflect a fee waiver in effect and in the absence of this waiver, the total returns would be lower. Index performance is not illustrative of fund performance. One cannot invest directly in an index. 

Performance data shown for Global Innovators, Institutional Class (GINNX), prior to its launch date on 12/31/15, uses performance data from the Global Innovators, Investor Class (IWIRX) (inception date 12/15/98). 

For Financial Professional Use Only  –  Not For Use with the Investing Public

Click Here for the prospectus. 

Opinions expressed are subject to change at any time, are not guaranteed and should not be considered investment advice.

Click Here to view Fund holdings.

Fund holdings and sector allocations are subject to change and are not recommendations to buy or sell any security.